The Ombuds Blog: Pfizer Ombuds Office Marks 10-Year Anniversary

December 01, 2021

Pfizer Ombuds Office Marks 10-Year Anniversary

The Office of the Ombuds at Pfizer is celebrating ten years of service to the American multinational pharmaceutical and biotechnology corporation. The office has posted a celebratory video that includes thanks and encouragement from five of Pfizer's Executive Leadership Team members including the CEO, General Counsel, and Chief Compliance Officer. Sue Diviney is the Office of the Ombuds Lead and her team includes: Lourdes Delgado-Cheers, Global Ombuds; Tara Hunter, Specialist; Adam Learman, Global Ombuds; Elizabeth Lopez, Ombuds; and Sophia Qiao, Ombuds APAC. (Pfizer Video.)
Related posts: Court Approves Settlement Creating Ombuds Program for Pfizer; Pfizer Ombuds Ready to Address #MeToo Claims; Summer 2019 Meeting of Colorado Ombuds Includes Swag; IOA Board Appoints New Director to Open Seat; Pfizer Adds an Ombuds in Colorado

No comments:

Organizational Ombuds

Organizational Ombuds serve as a confidential, independent, neutral and informal dispute resolution resource for a specific entity. They are accessible to a defined population and can advocate for fairness. These unique characteristics distinguish Organizational Ombuds from Classical Ombuds, mediators, arbitrators, and other alternative dispute resolution professionals. The term "Ombuds" is shorthand for "Ombudsman," "Ombudsperson" and "Ombuds Officer," which also are used widely.

Some other variants include:

Austria -- Ombudsstelle

Brazil -- Ouvidor

Croatia -- pravobranitelji

France -- médiateur/defénseur

Germany -- Ombudspersonen

Italy -- difensore

Netherlands -- ombudspersoon

Norway -- ombudet

Poland -- Rzecznik

Portugal -- provedor

Russia -- омбудсмен

Spain -- ombudsman organizacional

Sweden -- studentombud

Switzerland -- ombudsmann

Comment Policy

Content and Relevance

Stay on topic: Comments should be relevant to the post.
Be respectful: Personal attacks, insults, profanity, inflammatory language, and discriminatory or harassing comments will not be tolerated.
No self-promotion or spam: Comments should contribute to the conversation and not be used to for commercial purposes.
No confidential information: Do not share confidential information about your organization or visitors.

Length and Format

Keep it concise: Comments should be clear and to the point. Excessively long comments may be edited for clarity and length.
Use appropriate formatting: Do not use all caps unnecessarily. Comments may include HTML formatting for readability.

Other Considerations

Be professional and respectful: Please be mindful of your content, even when commending anonymously.
Comments may be edited: I reserve the right to remove or edit any comments that violate these guidelines. My edits will be noted.
Complaints about IOA: This is not the appropriate forum to lodge formal complaints against the International Ombuds Association.
Guest editorials: Please email me directly to discuss a guest editorial offering a longer, more in-depth perspective on a topic related to the organizational ombuds profession

December 01, 2021

Pfizer Ombuds Office Marks 10-Year Anniversary

No comments:

Post a Comment